Pure Global AI
ANVISA registration 10009010509Valid until Jul 06, 2036

HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV) ANTIGEN AND ANTIBODY

ANVISA Registration Number: 10009010509LABTEST DIAGNOSTICA S/ALABTEST DIAGNOSTICA S/ARisk Class IV
Verified
Device names
Technical name
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV) ANTIGEN AND ANTIBODY
View exact technical-name matches →
PT: ANTÍGENO E ANTICORPO DO VÍRUS DA IMUNODEFICIÊNCIA HUMANA ADQUIRIDA TIPO 1 E TIPO 2 (HIV)
Commercial name
Família HIV Ag/Ab Combo Cartridge
View exact commercial-name matches →
Risk class
Class IV
Registration details
Registration Number
10009010509
Process Number
25351233134202512
CNPJ
16516296000138
Company information
Registration Holder
LABTEST DIAGNOSTICA S/A
Manufacturer
LABTEST DIAGNOSTICA S/A
Manufacturing Country
Brazil
PT: BRASIL
Dates and status
Publication Date
Jul 06, 2026
Validity
06/07/2036
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV) ANTIGEN AND ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10009010509 and manufactured by LABTEST DIAGNOSTICA S/A. The registration is held by LABTEST DIAGNOSTICA S/A with validity until Jul 06, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.